Are ME/CFS and long COVID similar conditions, with the only difference being the trigger driving their development? Scientists evaluated levels of depressive symptoms, fatigue, sleep quality, anxiety, and olfactory and cognitive functions in 42 ME/CFS patients and 73 long COVID patients to find out if this is the case.
Read More »This Week in Virology podcast discusses the finding that infection with SARS-CoV-2 leads to an increase in new and preexisting autoantibodies. Find the episode here!
Read More »Researchers in Hungary investigated the efficacy of COVID-19 boosters in patients with autoimmune rheumatic and musculoskeletal diseases. They also studied whether a SARS-CoV-2 infection following a two-dose primary series increased antibody production by the immune system in lieu of a booster.
Read More »Researchers created an online questionnaire for RA and AIRD patients to self-report short-term COVID-19 vaccine-related adverse events. Vaccines included in the study were Pfizer, Moderna, Johnson & Johnson, AstraZeneca, Covaxin, and Sinopharm. The most common coexisting autoimmune diseases were thyroid disorders, systemic lupus erythematosus (SLE) and Sjogren’s syndrome (10.0%, 2.6%, and 2.5%, respectively).
Read More »